Press Release: ProSolus : Canoa Inc. Acquires Privately-Held ProSolus Inc., Accelerating Transdermal Patch Drug Delivery Product Development

Canoa Inc. (“Canoaâ€), a Delaware corporation with a focus on healthcare and pharmaceuticals, has acquired ProSolus® Inc. (“ProSolusâ€), from Mission Pharmacal® Company, in an all-cash transaction. ProSolus is a private pharmaceutical company with an expertise in transdermal drug delivery systems. “This transaction will create one of the leading pure-play transdermal pharmaceutical companies in the United... Read more »The post Canoa Inc. Acquires Privately-Held ProSolus Inc., Accelerating Transdermal Patch Drug Delivery Product Development appeared first on University Chronicle.